Breaking News Instant updates and real-time market news.

2022-10-25 11:16:02 $NYE NYSE Market Internals / + 11:16 10/25/22 10/25 11:16 10/25/22 11:16	NYSE market internals summary Volume is above average for this time of day. Breadth is mixed with issues and volume bullish while new highs to new lows are bearish (negative divergence). Advancing Issues: 2512 / Declining Issues: 515 -- for a ratio of 4.9 to 1. Advancing Volume: 1,090,011,000 / Declining Volume: 300,700,000 -- for a ratio of 3.6 to 1. New 52-Week Highs: 43 / New 52-Week Lows: 69.

2022-10-25 11:16:02

$NYE

NYSE Market Internals

/ +

11:16

10/25/22

10/25

11:16

10/25/22

11:16

NYSE market internals summary

Volume is above average for this time of day. Breadth is mixed with issues and volume bullish while new highs to new lows are bearish (negative divergence). Advancing Issues: 2512 / Declining Issues: 515 -- for a ratio of 4.9 to 1. Advancing Volume: 1,090,011,000 / Declining Volume: 300,700,000 -- for a ratio of 3.6 to 1. New 52-Week Highs: 43 / New 52-Week Lows: 69.

OTHER BREAKING NEWS FROM THE FLY

Upgrade	Essity upgraded to Neutral from Underweight at JPMorgan » 04:59 12/01/22 12/01 04:59 12/01/22 04:59 ETTYF Essity $22.85 / -1.017 (-4.26%) JPMorgan analyst Celine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ETTYF Essity $22.85 / -1.017 (-4.26%) 11/22/22 Exane BNP Paribas Essity upgraded to Outperform from Neutral at Exane BNP Paribas 11/01/22 Berenberg Essity price target lowered to SEK 254 from SEK 266 at Berenberg 10/28/22 JPMorgan Essity price target raised to SEK 220 from SEK 210 at JPMorgan 10/28/22 Credit Suisse Essity price target lowered to SEK 286 from SEK 308 at Credit Suisse
Downgrade	Givaudan downgraded to Underweight from Neutral at JPMorgan » 04:59 12/01/22 12/01 04:59 12/01/22 04:59 GVDNY Givaudan $67.37 / +1.7 (+2.59%) JPMorgan analyst Celine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events GVDNY Givaudan $67.37 / +1.7 (+2.59%) 09/23/22 Givaudan, LanzaTech collaborate to develop sustainable fragrance ingredients GVDNY Givaudan $67.37 / +1.7 (+2.59%) 10/13/22 Berenberg Givaudan price target lowered to CHF 3,600 from CHF 3,800 at Berenberg 10/12/22 JPMorgan Givaudan price target lowered to CHF 2,700 from CHF 3,300 at JPMorgan 10/12/22 Credit Suisse Givaudan price target lowered to CHF 2,400 from CHF 2,900 at Credit Suisse 09/29/22 Citi Givaudan upgraded to Buy from Neutral at Citi 01/25/23 Givaudan - GVDNY
Downgrade	Remy Cointreau downgraded to Underweight from Neutral at JPMorgan » 04:58 12/01/22 12/01 04:58 12/01/22 04:58 REMYY Remy Cointreau $17.26 / +0.56 (+3.35%) JPMorgan analyst Celine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research REMYY Remy Cointreau $17.26 / +0.56 (+3.35%) 10/26/22 Credit Suisse Remy Cointreau price target lowered to EUR 155 from EUR 190 at Credit Suisse 10/26/22 Barclays Remy Cointreau price target lowered to EUR 257 from EUR 325 at Barclays 10/12/22 Morgan Stanley Remy Cointreau price target lowered to EUR 155 from EUR 160 at Morgan Stanley 09/12/22 Deutsche Bank Remy Cointreau price target raised to EUR 310 from EUR 304 at Deutsche Bank
Downgrade	Davide Campari-Milano downgraded to Neutral from Overweight at JPMorgan » 04:57 12/01/22 12/01 04:57 12/01/22 04:57 DVDCF Davide Campari-Milano $10.90 / + (+0.00%) JPMorgan analyst Celine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DVDCF Davide Campari-Milano $10.90 / + (+0.00%) 11/08/22 Morgan Stanley Davide Campari-Milano price target lowered to EUR 9.30 at Morgan Stanley 11/02/22 Societe Generale Davide Campari-Milano price target lowered to EUR 12 at Societe Generale 11/01/22 Credit Suisse Davide Campari-Milano price target lowered to EUR 10 from EUR 11.90 at Credit Suisse 11/01/22 Deutsche Bank Davide Campari-Milano upgraded to Buy from Hold at Deutsche Bank
Downgrade	L'Oreal downgraded to Neutral from Overweight at JPMorgan » 04:56 12/01/22 12/01 04:56 12/01/22 04:56 LRLCY L'Oreal $74.41 / +2.458 (+3.42%) JPMorgan analyst Celine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings LRLCY L'Oreal $74.41 / +2.458 (+3.42%) 09/14/22 PFSweb deploys pop-up fulfillment operation for L'Oreal brand SkinCeuticals 07/29/22 Colgate-Palmolive names Habif CTO LRLCY L'Oreal $74.41 / +2.458 (+3.42%) 10/25/22 Berenberg L'Oreal price target lowered to EUR 314 from EUR 347 at Berenberg 10/24/22 Barclays L'Oreal price target lowered to EUR 375 from EUR 416 at Barclays 10/11/22 Morgan Stanley L'Oreal price target lowered to EUR 365 from EUR 385 at Morgan Stanley 10/11/22 Deutsche Bank L'Oreal price target lowered to EUR 380 from EUR 400 at Deutsche Bank LRLCY L'Oreal $74.41 / +2.458 (+3.42%) 10/20/22 L'Oreal reports Q3 total sales EUR 9.58B, up 9.1% on a like-for-like basis 07/28/22 L'Oreal reports 1H EPS up 30.8% to EUR 6.05, sales EUR 18.36B
Conference/Events	Senate Agriculture, Nutrition & Forrestry Committee to hold a hearing » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 The Committee holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	UBS semiconductor analyst to hold an analyst/industry conference call » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 ADI Analog Devices $171.83 / +7.89 (+4.81%) Semiconductors Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options ADI Analog Devices $171.83 / +7.89 (+4.81%) 11/17/22 AMD, Analog Devices resolve all ongoing patent litigations 11/14/22 Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3 10/26/22 Desktop Metal announces Jason Cole to join as CFO 06/27/22 Analog Devices appoints Andonian to board of directors ADI Analog Devices $171.83 / +7.89 (+4.81%) 11/23/22 Deutsche Bank Analog Devices price target raised to $170 from $155 at Deutsche Bank 11/23/22 Evercore ISI Analog Devices price target raised to $195 from $185 at Evercore ISI 11/23/22 Truist Analog Devices price target raised to $214 from $209 at Truist 11/23/22 Cowen Analog Devices price target raised to $190 from $180 at Cowen ADI Analog Devices $171.83 / +7.89 (+4.81%) 11/22/22 Analog Devices reports Q4 EPS $2.73, consensus $2.58 11/21/22 Notable companies reporting before tomorrow's open 11/21/22 Notable companies reporting before tomorrow's open 08/17/22 Analog Devices sees Q4 adjusted EPS $2.57 +/- 10c, consensus $2.50 ADI Analog Devices $171.83 / +7.89 (+4.81%) 11/22/22 Fly Intel: Pre-market Movers 10/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/30/22 What You Missed On Wall Street This Morning 08/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/04/23 Truist Hosted Company Meetings at CES 2023 ADI Analog Devices $171.83 / +7.89 (+4.81%) 10/18/22 Analog Devices put volume heavy and directionally bearish 10/10/22 Analog Devices put volume heavy and directionally bearish 06/13/22 Analog Devices call volume above normal and directionally bullish
Conference/Events	Intellia Therapeutics to participate in a conference call with JPMorgan » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 NTLA Intellia Therapeutics $51.41 / +3.44 (+7.17%) SMid Cap Biotech Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events NTLA Intellia Therapeutics $51.41 / +3.44 (+7.17%) 11/13/22 Intellia presents new interim data from first-in-human study of NTLA-2002 in HAE 11/06/22 Intellia presents interim data from cardiomyopathy arm of Phase 1 study of '2001 09/19/22 Cathie Wood's ARK Investment bought 71K shares of Intellia Therapeutics today 09/16/22 Intellia, Regeneron announce initial data from Phase 1 study of NTLA-2001 NTLA Intellia Therapeutics $51.41 / +3.44 (+7.17%) 11/14/22 Chardan Intellia Therapeutics price target raised to $129 from $121 at Chardan 11/03/22 Chardan Intellia Therapeutics price target lowered to $121 from $146 at Chardan 10/31/22 EF Hutton Intellia Therapeutics initiated with a Buy at EF Hutton 10/11/22 Morgan Stanley Intellia Therapeutics initiated with an Overweight at Morgan Stanley NTLA Intellia Therapeutics $51.41 / +3.44 (+7.17%) 11/03/22 Intellia Therapeutics reports Q3 EPS ($1.49), consensus ($1.28) 08/04/22 Intellia Therapeutics reports Q2 EPS ($1.33), consensus ($1.31) 01 Dec NTLA Intellia Therapeutics $51.41 / +3.44 (+7.17%) 07/25/22 Researchers warn CRISPR gene editing may trigger cancer, Jerusalem Post says NTLA Intellia Therapeutics $51.41 / +3.44 (+7.17%) 11/11/22 Sell these stocks now, proven algorithm says 09/23/22 Sell these stocks now, proven algorithm says 09/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/16/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11:00 Today Intellia Therapeutics - NTLA
Conference/Events	Standard Motor management to meet virtually with MKM Partners » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 SMP Standard Motor $38.37 / +0.6 (+1.59%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SMP Standard Motor $38.37 / +0.6 (+1.59%) 10/05/22 Standard Motor acquires Kade Trading SMP Standard Motor $38.37 / +0.6 (+1.59%) 10/18/22 MKM Partners Standard Motor price target lowered to $47 from $57 at MKM Partners 06/09/22 MKM Partners Standard Motor initiated with a Buy at MKM Partners SMP Standard Motor $38.37 / +0.6 (+1.59%) 10/28/22 Standard Motor reports Q3 adjusted EPS $1.05, consensus 97c 08/03/22 Standard Motor reports Q2 non-GAAP EPS 93c, consensus $1.18 SMP Standard Motor $38.37 / +0.6 (+1.59%) 06/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 00:00 Today Standard Motor
Conference/Events	Humana to participate in a conference call with Mizuho » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 HUM Humana $550.14 / +16.53 (+3.10%) Conference call to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HUM Humana $550.14 / +16.53 (+3.10%) 11/14/22 Starboard takes stake in Wix.com, exits Elanco Animal Health 10/26/22 Humana, Monogram Health announce value-based care agreement 10/25/22 Humana offering Medicare Advantage plans in two new states 10/24/22 Humana and Cohere Health expand partnership for presurgical authorization HUM Humana $550.14 / +16.53 (+3.10%) 11/08/22 Wells Fargo Humana price target raised to $610 from $558 at Wells Fargo 11/07/22 Cowen Humana price target raised to $647 from $547 at Cowen 11/03/22 Truist Humana price target raised to $650 from $570 at Truist 11/03/22 RBC Capital Humana price target raised to $637 from $560 at RBC Capital HUM Humana $550.14 / +16.53 (+3.10%) 11/02/22 Humana backs FY22 adjusted EPS view 'approximately $25.00,' consensus $25.03 11/02/22 Humana reports Q3 adjusted EPS $6.88, consensus $6.28 11/01/22 Notable companies reporting before tomorrow's open 11/01/22 Notable companies reporting before tomorrow's open HUM Humana $550.14 / +16.53 (+3.10%) 11/29/22 Managed care company returns will be tough to keep replicating, WSJ says 11/29/22 Humana to shut down Jupiter, FL, facility, cut 150+ jobs, SFBJ reports 10/07/22 Cano jumps after Bloomberg says CVS in exclusive buyout talks 09/22/22 CVS Health said to weigh possible bid for Cano Health, Bloomberg says HUM Humana $550.14 / +16.53 (+3.10%) 10/26/22 What You Missed On Wall Street This Morning 10/26/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/23/22 What You Missed On Wall Street On Friday 09/22/22 What You Missed On Wall Street On Thursday 00:00 Today Humana - HUM HUM Humana $550.14 / +16.53 (+3.10%) 09/15/22 Early notable gainers among liquid option names on September 15th

Hot Stocks	Sabre to replace Flagstar Bancorp in the S&P 600 at open on 12/1 » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 SABR Sabre $6.10 / +0.325 (+5.63%) , FBC Flagstar Bancorp $37.55 / +0.45 (+1.21%) Nexstar Media Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SABR FBC SABR Sabre $6.10 / +0.325 (+5.63%) 04:55 Today Sabre to replace Flagstar Bancorp in the S&P 600 at open on 12/1 04:55 Today Nexstar to replace Sabre in the S&P 400 at open on 12/1 11/28/22 Sabre to replace Flagstar Bancorp in the S&P 600 at open on 12/1 11/28/22 Nexstar to replace Sabre in the S&P 400 at open on 12/1 FBC Flagstar Bancorp $37.55 / +0.45 (+1.21%) 04:55 Today Sabre to replace Flagstar Bancorp in the S&P 600 at open on 12/1 11/28/22 Sabre to replace Flagstar Bancorp in the S&P 600 at open on 12/1 11/07/22 New York Community Bancorp approved for Flagstar Bancorp acquisition 10/28/22 Flagstar Bancorp rises 13.7% SABR FBC SABR Sabre $6.10 / +0.325 (+5.63%) 10/17/22 Mizuho Sabre price target lowered to $6 from $7 at Mizuho 09/28/22 Redburn Sabre initiated with a Buy at Redburn 09/08/22 Mizuho Sabre price target lowered to $7 from $8 at Mizuho 08/22/22 Mizuho Sabre price target raised to $8 from $7 at Mizuho FBC Flagstar Bancorp $37.55 / +0.45 (+1.21%) 07/11/22 B. Riley Flagstar Bancorp price target lowered to $40 from $44 at B. Riley 06/14/22 B. Riley Flagstar Bancorp downgraded to Neutral from Buy at B. Riley 06/14/22 B. Riley Flagstar Bancorp downgraded to Neutral from Buy at B. Riley 06/02/22 Keefe Bruyette New York Community downgraded to Market Perform at Keefe Bruyette SABR FBC SABR Sabre $6.10 / +0.325 (+5.63%) 11/02/22 Sabre sees FY22 adjusted EBITDA ~$90M 11/02/22 Sabre sees Q4 adjusted EBITDA ~$30M 11/02/22 Sabre reports Q3 adjusted EPS (25c), consensus (25c) 08/02/22 Sabre now sees FY22 revenue $2.3B-$2.6B at 50% bookings recovery FBC Flagstar Bancorp $37.55 / +0.45 (+1.21%) 10/26/22 Flagstar Bancorp reports Q3 adjusted EPS $1.41, consensus $1.24 07/27/22 Flagstar Bancorp reports Q2 adjusted EPS $1.17, consensus $1.08 SABR FBC SABR Sabre $6.10 / +0.325 (+5.63%) 09/28/22 Sabre quietly looking to shed hotel software unit, Skift reports FBC Flagstar Bancorp $37.55 / +0.45 (+1.21%) 06/21/22 Flagstar revealed data breach for 1.5M customers, American Banker reports SABR SABR Sabre $6.10 / +0.325 (+5.63%) 11/29/22 What You Missed On Wall Street On Tuesday 11/29/22 What You Missed On Wall Street This Morning 11/28/22 Fly Intel: After-Hours Movers 09/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations SABR SABR Sabre $6.10 / +0.325 (+5.63%) 10/20/22 Sabre put volume heavy and directionally bearish 08/19/22 Sabre call volume above normal and directionally bullish 08/08/22 Sabre put volume heavy and directionally bearish 07/28/22 Sabre put volume heavy and directionally bearish
Conference/Events	CCC Intelligent Solutions management to meet with Piper Sandler » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 CCCS CCC Intelligent Solutions $9.18 / +0.31 (+3.50%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate Events CCCS CCC Intelligent Solutions $9.18 / +0.31 (+3.50%) 11/01/22 Citi CCC Intelligent Solutions price target lowered to $10 from $11 at Citi 10/21/22 Barclays CCC Intelligent Solutions initiated with an Equal Weight at Barclays 08/08/22 Piper Sandler CCC Intelligent Solutions initiated with a Neutral at Piper Sandler 07/13/22 Goldman Sachs CCC Intelligent Solutions upgraded to Buy from Neutral at Goldman Sachs CCCS CCC Intelligent Solutions $9.18 / +0.31 (+3.50%) 08/04/22 CCC Intelligent Solutions sees Q3 revenue $194M-$196M, consensus $192.1M 08/04/22 CCC Intelligent Solutions sees FY22 revenue $773M-$777M, consensus $768.9M 08/04/22 CCC Intelligent Solutions reports Q2 EPS 2c, consensus 8c 07 Apr 00:00 Today CCC Intelligent Solutions
Conference/Events	S&P Global to host investor day » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 SPGI S&P Global $352.79 / +6.24 (+1.80%) Investor Day to be held… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SPGI S&P Global $352.79 / +6.24 (+1.80%) 11/30/22 S&P Global plans to divest its Engineering Solutions business 11/14/22 S&P Global reaches settlement with SEC 09/21/22 S&P Global and Novata announce strategic partnership 08/29/22 S&P Global announces full acquisition of PMC SPGI S&P Global $352.79 / +6.24 (+1.80%) 11/28/22 BMO Capital S&P Global price target raised to $393 from $355 at BMO Capital 11/07/22 Atlantic Equities Atlantic upgrades S&P Global to Overweight on 'high-quality' business 11/07/22 Atlantic Equities S&P Global upgraded to Overweight from Neutral at Atlantic Equities 11/01/22 Argus S&P Global price target lowered to $365 from $420 at Argus SPGI S&P Global $352.79 / +6.24 (+1.80%) 10/27/22 S&P Global cuts FY22 adjusted EPS view to $11.00-$11.15 from $11.35-$11.55 10/27/22 S&P Global reports Q3 adjusted EPS $2.93, consensus $2.79 08/02/22 S&P Global sees FY22 adjusted EPS $11.35-$11.55, consensus $12.24 08/02/22 S&P Global reports Q2 adjusted EPS $2.81, consensus $2.93 SPGI S&P Global $352.79 / +6.24 (+1.80%) 06/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning 06/01/22 Fly Intel: Pre-market Movers 13:00 Today S&P Global
Conference/Events	Needham healthcare analyst to hold an analyst/industry conference call » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 ALC Alcon $68.89 / +1.585 (+2.36%) , BLCO Bausch + Lomb $15.13 / +0.61 (+4.20%) , COO Cooper Companies $316.13 / +8.85 (+2.88%) , GKOS Glaukos $46.51 / +0.84 (+1.84%) , JNJ Johnson & Johnson $177.94 / +1.895 (+1.08%) , RXST RxSight $12.75 / +0.64 (+5.28%) , SGHT Sight Sciences $11.08 / +0.53 (+5.02%) , STAA Staar Surgical $57.04 / +1.61 (+2.90%) Healthcare Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ALC BLCO COO GKOS JNJ SGHT STAA ALC Alcon $68.89 / +1.585 (+2.36%) 11/01/22 MKS Instruments appoints Chang as Senior Vice President, General Manager, Asia 10/27/22 Cassava Sciences appoints Cook as SVP, general counsel 08/23/22 Alcon acquires Aerie Pharmaceuticals for $15.25 per share or $770M 07/11/22 Kala Pharmaceuticals completes sale of EYSUVIS, INVELTYS to Alcon BLCO Bausch + Lomb $15.13 / +0.61 (+4.20%) 09/06/22 Bausch + Lomb, Novaliq announces US FDA accepted NDA for NOV03 09/01/22 Bausch + Lomb named exclusive distributor of Alfa Instruments' intraocular dyes 08/15/22 Icahn buys Bausch + Lomb, exits Delek in Q2 08/01/22 Candel Therapeutics appoints three new members to board of directors COO Cooper Companies $316.13 / +8.85 (+2.88%) 08/09/22 Cooper Companies appoints Nicholas Khadder general counsel GKOS Glaukos $46.51 / +0.84 (+1.84%) 09/07/22 Glaukos rises 19.5% 09/07/22 Glaukos rises 12.2% 09/07/22 Glaukos rises 7.6% 09/07/22 Glaukos announces two iDose TR trials met primary endpoints JNJ Johnson & Johnson $177.94 / +1.895 (+1.08%) 11/30/22 Johnson & Johnson names CEO Joaquin Duato as Chairman of the Board 11/30/22 AC Immune's ACI-35.030 selected for further development 11/29/22 Horizon Therapeutics jumps 33% after deal talks with Amgen, Janssen, Sanofi 11/29/22 Horizon Therapeutics confirms preliminary deal talks with Amgen, Janssen, Sanofi SGHT Sight Sciences $11.08 / +0.53 (+5.02%) 11/03/22 Sight Sciences announces publication of clinical data on OMNI system 09/29/22 Sight Sciences announces publication of data on TearCare system 09/13/22 Sight Sciences completes enrollment in SAHARA Trial 08/23/22 Sight Sciences announces the launch of SION surgical instrument STAA Staar Surgical $57.04 / +1.61 (+2.90%) 06/07/22 Staar Surgical announces more than 2M Visian ICLs sold globally ALC BLCO COO GKOS JNJ RXST SGHT STAA ALC Alcon $68.89 / +1.585 (+2.36%) 11/21/22 Credit Suisse Alcon price target lowered to CHF 80 from CHF 84 at Credit Suisse 11/17/22 Societe Generale Societe Generale downgrades Alcon to Sell with Q3 'last good quarter' 11/17/22 Societe Generale Alcon downgraded to Sell from Hold at Societe Generale 11/17/22 Wells Fargo Alcon price target lowered to $83 from $90 at Wells Fargo BLCO Bausch + Lomb $15.13 / +0.61 (+4.20%) 11/03/22 H.C. Wainwright Bausch + Lomb price target lowered to $20 from $21 at H.C. Wainwright 09/12/22 H.C. Wainwright Bausch + Lomb initiated with a Buy at H.C. Wainwright 07/28/22 RBC Capital RBC says court ruling on Xifaxan looks like 'worst possible outcome' for Bausch 07/28/22 JPMorgan JPMorgan downgrades Bausch on 'near-worst-case scenario' ruling COO Cooper Companies $316.13 / +8.85 (+2.88%) 11/30/22 Baird Cooper Companies upgraded to Outperform from Neutral at Baird 11/28/22 JPMorgan Cooper Companies price target raised to $330 from $300 at JPMorgan 11/03/22 Piper Sandler Cooper Companies price target lowered to $355 from $375 at Piper Sandler 10/11/22 Jefferies Cooper Companies downgraded to Hold from Buy at Jefferies GKOS Glaukos $46.51 / +0.84 (+1.84%) 11/03/22 Piper Sandler Glaukos price target raised to $60 from $55 at Piper Sandler 10/13/22 Stephens Glaukos resumed with an Overweight at Stephens 10/12/22 Piper Sandler CMS proposal a positive for Med Tech sector, says Piper Sandler 10/05/22 Citi Glaukos price target raised to $57 from $54 at Citi JNJ Johnson & Johnson $177.94 / +1.895 (+1.08%) 11/30/22 Wells Fargo Horizon Therapeutics takeover value could be $135/share, says Wells Fargo 11/29/22 Craig-Hallum Craig-Hallum sees potential for competing Apollo Endosurgery bids 11/28/22 Morgan Stanley Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley 11/17/22 Credit Suisse Johnson & Johnson initiated with a Neutral at Credit Suisse RXST RxSight $12.75 / +0.64 (+5.28%) 10/11/22 BofA RxSight reinstated with a Buy at BofA 04/19/22 BTIG J&J results will be viewed favorably for MedTech group, says BTIG 04/08/22 Needham RxSight initiated with a Buy at Needham SGHT Sight Sciences $11.08 / +0.53 (+5.02%) 10/12/22 Piper Sandler CMS proposal a positive for Med Tech sector, says Piper Sandler 10/11/22 BofA Sight Sciences reinstated with a Neutral at BofA 10/05/22 Citi Sight Sciences price target lowered to $9 from $13 at Citi 10/04/22 Needham Sight Sciences initiated with a Hold at Needham STAA Staar Surgical $57.04 / +1.61 (+2.90%) 11/30/22 Canaccord Staar Surgical price target lowered to $79 from $88 at Canaccord 11/07/22 Sidoti Staar Surgical upgraded to Buy from Neutral at Sidoti 11/03/22 Needham Staar Surgical price target lowered to $83 from $110 at Needham 11/03/22 BTIG Staar Surgical price target lowered to $80 from $103 at BTIG ALC BLCO COO GKOS JNJ RXST SGHT STAA ALC Alcon $68.89 / +1.585 (+2.36%) 11/15/22 Alcon narrows FY22 EPS view to $2.20-$2.25 from $2.20-$2.30 11/15/22 Alcon reports Q3 core EPS 50c, consensus 48c 08/09/22 Alcon cuts FY22 core EPS view to $2.20-$2.30 from $2.35-$2.45 08/09/22 Alcon reports Q2 core EPS 63c, consensus 49c BLCO Bausch + Lomb $15.13 / +0.61 (+4.20%) 06/08/22 Bausch + Lomb sees 2022 revenue $3.75B-$3.8B 06/08/22 Bausch + Lomb reports Q1 adjusted EPS 24c vs. 27c last year 06/07/22 Notable companies reporting before tomorrow's open COO Cooper Companies $316.13 / +8.85 (+2.88%) 08/31/22 Cooper Companies sees Q4 revenue $830M - $850M, consensus $841.43M 08/31/22 Cooper Companies sees Q EPS12.72 - $12.87 , consensus $13.14 08/31/22 Cooper Companies sees Q4 EPS $3.05-$3.20, consensus $3.42 08/31/22 Cooper Companies reports Q3 EPS $3.19, consensus $3.23 GKOS Glaukos $46.51 / +0.84 (+1.84%) 11/02/22 Glaukos narrows FY22 revenue view to $278M-$280M from $275M-$280M 11/02/22 Glaukos reports Q3 adjusted EPS (45c), consensus (52c) 08/03/22 Glaukos sees FY22 revenue $275M-$280M, consensus $274.4M 08/03/22 Glaukos reports Q2 EPS (83c), consensus (44c) JNJ Johnson & Johnson $177.94 / +1.895 (+1.08%) 10/18/22 Johnson & Johnson cuts FY22 estimated reported sales view to $93.0B-$93.5B 10/18/22 Johnson & Johnson narrows FY22 adjusted operational EPS view to $10.70-$10.75 10/18/22 Johnson & Johnson narrows FY22 adjusted EPS view to $10.02-$10.07 10/18/22 Johnson & Johnson reports Q3 adjusted EPS $2.55, consensus $2.48 RXST RxSight $12.75 / +0.64 (+5.28%) 11/07/22 RxSight raises FY22 revenue view to $47M-$48M from prior $44M-$46M 11/07/22 RxSight reports Q3 EPS (61c), consensus (71c) 08/08/22 RxSight raises FY22 revenue view to $44M-$46M from $41.5M-$45.5M 08/08/22 RxSight reports Q2 EPS adjusted EPS (50c) vs ($3.24) last year SGHT Sight Sciences $11.08 / +0.53 (+5.02%) 11/10/22 Sight Sciences raises FY22 revenue view to $70M-$72M from $68M-$72M 11/10/22 Sight Sciences reports Q3 EPS (46c), consensus (46c) 08/11/22 Sight Sciences sees FY22 revenue $68M-$72M, consensus $69.83M 08/11/22 Sight Sciences reports Q2 EPS (50c), consensus (42c) STAA Staar Surgical $57.04 / +1.61 (+2.90%) 11/02/22 Staar Surgical sees 2022 revenue $285M, consensus $294.94M 11/02/22 Staar Surgical reports Q3 EPS 21c, consensus 13c 08/10/22 Staar Surgical reports Q2 EPS 26c vs 17c last year 06 May JNJ JNJ Johnson & Johnson $177.94 / +1.895 (+1.08%) 11/07/22 Biogen weighing new CEO options after talks with J&J exec hit impasse, STAT says 10/20/22 CDC panel says COVID shots to be added to regular vaccinations, WSJ says 10/20/22 Drugmakers look to limit Medicare's power to negotiate drug prices, WSJ reports 10/18/22 Johnson & Johnson likely to make 'modest' cuts to workforce, WSJ reports ALC BLCO COO GKOS JNJ ALC Alcon $68.89 / +1.585 (+2.36%) 11/16/22 What You Missed On Wall Street On Wednesday 11/16/22 What You Missed On Wall Street This Morning 08/23/22 What You Missed On Wall Street On Tuesday 08/23/22 What You Missed On Wall Street This Morning BLCO Bausch + Lomb $15.13 / +0.61 (+4.20%) 06/24/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/08/22 What You Missed On Wall Street On Wednesday 06/08/22 What You Missed On Wall Street This Morning 06/08/22 Fly Intel: Pre-market Movers COO Cooper Companies $316.13 / +8.85 (+2.88%) 11/30/22 What You Missed On Wall Street On Wednesday 11/30/22 What You Missed On Wall Street This Morning 11/30/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations GKOS Glaukos $46.51 / +0.84 (+1.84%) 10/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/12/22 What You Missed On Wall Street On Tuesday 07/12/22 What You Missed On Wall Street This Morning 07/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations JNJ Johnson & Johnson $177.94 / +1.895 (+1.08%) 11/30/22 What You Missed On Wall Street On Wednesday 11/30/22 What You Missed On Wall Street This Morning 11/30/22 Fly Intel: Pre-market Movers 11/08/22 What You Missed On Wall Street On Tuesday 11:00 Today Emerging Biotechnology 13:00 Today Healthcare 12/08/22 Pharma/Biotech--Luncheon 12/08/22 Pharma/Biotech 12/14/22 Biotech/Biopharma 12/12/22 ASH Annual Meeting & Expo 2022 12/08/22 Cooper Companies - COO JNJ RXST JNJ Johnson & Johnson $177.94 / +1.895 (+1.08%) 11/11/22 Johnson & Johnson put volume heavy and directionally bearish 10/18/22 Unusually active option classes on open October 18th 09/20/22 Johnson & Johnson put volume heavy and directionally bearish 07/19/22 Unusually active option classes on open July 19th RXST RxSight $12.75 / +0.64 (+5.28%) 08/24/22 Four new option listings on August 24th
Conference/Events	BTIG medical technology analyst to hold analyst/industry conference call » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 Medical Technology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Conference/Events	C.H. Robinson management to meet with Stephens » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 CHRW C.H. Robinson $99.61 / +2.615 (+2.70%) Meetings to be held with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CHRW C.H. Robinson $99.61 / +2.615 (+2.70%) 11/17/22 C.H. Robinson raises quarterly dividend to 61c per share from 55c 11/02/22 C.H. Robinson sees $175M of gross cost savings in Q4 CHRW C.H. Robinson $99.61 / +2.615 (+2.70%) 11/30/22 Exane BNP Paribas C.H. Robinson initiated with an Outperform at Exane BNP Paribas 11/30/22 BofA RXO Inc. initiated with a Buy at BofA 11/15/22 Raymond James C.H. Robinson downgraded to Underperform from Market Perform at Raymond James 11/15/22 Raymond James C.H. Robinson downgraded to Underperform from Market Perform at Raymond James CHRW C.H. Robinson $99.61 / +2.615 (+2.70%) 11/02/22 C.H. Robinson reports Q3 EPS $1.78, consensus $2.17 07/27/22 C.H. Robinson reports Q2 EPS $2.67, consensus $1.98 CHRW C.H. Robinson $99.61 / +2.615 (+2.70%) 06/14/22 DSV interested in acquiring C.H. Robinson's global forwarding unit, Reuters says CHRW C.H. Robinson $99.61 / +2.615 (+2.70%) 09/15/22 Fly Intel: After-Hours Movers 00:00 Today C.H. Robinson CHRW C.H. Robinson $99.61 / +2.615 (+2.70%) 06/14/22 Early notable gainers among liquid option names on June 14th
Conference/Events	TPG RE Finance management to meet with BTIG » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 TRTX TPG RE Finance $7.42 / +0.315 (+4.43%) Mortgage and Specialty… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events TRTX TPG RE Finance $7.42 / +0.315 (+4.43%) 11/21/22 BofA TPG RE Finance reinstated with a Neutral at BofA 11/02/22 BTIG TPG RE Finance downgraded to Neutral from Buy at BTIG 10/24/22 JPMorgan TPG RE Finance price target lowered to $9 from $9.50 at JPMorgan 05/06/22 Citi TPG RE Finance price target lowered to $12 from $14 at Citi TRTX TPG RE Finance $7.42 / +0.315 (+4.43%) 11/01/22 TPG RE Finance reports Q2 EPS ($1.52), consensus 25c 08/02/22 TPG RE Finance reports Q1 EPS 25c, consensus 34c 00:00 Today TPG RE Finance
Conference/Events	Permian Resources management to meet with Truist » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 PR Permian Resources $10.16 / +0.06 (+0.59%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Street Research Events Options PR Permian Resources $10.16 / +0.06 (+0.59%) 11/17/22 Piper Sandler Permian Resources price target raised to $15 from $12 at Piper Sandler 10/26/22 Citi Permian Resources reinstated with a Buy at Citi 10/20/22 JPMorgan Permian Resources price target lowered to $11 from $12 at JPMorgan 10/18/22 Piper Sandler Permian Resources price target raised to $12 from $11 at Piper Sandler 12/15/22 Permian Resources PR Permian Resources $10.16 / +0.06 (+0.59%) 09/06/22 Notable open interest changes for September 6th 09/02/22 Two new option listings on September 2nd
Conference/Events	Grid Dynamics management to meet with Needham » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 GDYN Grid Dynamics $12.77 / +0.84 (+7.04%) Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events GDYN Grid Dynamics $12.77 / +0.84 (+7.04%) 11/30/22 Grid Dynamics inaugurates first engineering center in Hyderabad 10/31/22 Grid Dynamics achieves The AWS Service Delivery Designation for Amazon EKS 10/27/22 Grid Dynamics announces Churn Analytics Starter Kit for Vertex AI 10/11/22 Grid Dynamics announces launch of Modern Application Development practice GDYN Grid Dynamics $12.77 / +0.84 (+7.04%) 11/04/22 Citi Grid Dynamics price target lowered to $18 from $27 at Citi 10/14/22 JPMorgan Grid Dynamics price target lowered to $22 from $27 at JPMorgan 05/09/22 Northland Grid Dynamics price target raised to $25 from $22.50 at Northland 05/06/22 Citi Grid Dynamics price target raised to $23 from $20 at Citi 08 Sep GDYN Grid Dynamics $12.77 / +0.84 (+7.04%) 09/07/22 Fly Intel: After-Hours Movers 00:00 Today Grid Dynamics 12/22/22 Grid Dynamics Holdings Inc
Conference/Events	Netgear to hold virtual financial analyst day » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 NTGR Netgear $19.76 / +0.34 (+1.75%) 2022 Virtual Financial… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NTGR Netgear $19.76 / +0.34 (+1.75%) 10/11/22 Netgear selects LitePoint for next generation Wi-Fi 7products NTGR Netgear $19.76 / +0.34 (+1.75%) 07/28/22 BWS Financial Netgear upgraded to Buy from Neutral at BWS Financial 04/28/22 Deutsche Bank Netgear price target lowered to $22 from $25 at Deutsche Bank 04/19/22 Cowen Netgear's Q1 miss suggests challenges to persist, says Cowen 04/18/22 BWS Financial Netgear price target lowered to $27 from $30 at BWS Financial NTGR Netgear $19.76 / +0.34 (+1.75%) 10/26/22 Netgear sees Q4 revenue $235M-$250M, consensus $270.56M 10/26/22 Netgear reports Q3 adjusted EPS 21c, consensus 8c 07/27/22 Netgear sees Q3 revenue $240M-$255M, consensus $231.8M 07/27/22 Netgear reports Q2 EPS (19c), consensus (24c) NTGR Netgear $19.76 / +0.34 (+1.75%) 10/26/22 Fly Intel: After-Hours Movers 07/27/22 Fly Intel: After-Hours Movers 11:00 Today Netgear

Conference/Events	SharpLink Gaming to host conference call » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 SBET SharpLink Gaming / + CEO Phythian holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News On The Fly Events SBET SharpLink Gaming / + 11/10/22 Entrypoint to acquire SharpLink's legacy telecommunications business 11/09/22 SharpLink Gaming appoints Dave Abbott as CTO 11/09/22 SharpLink Gaming receives non-compliance notice from Nasdaq 11/09/22 SharpLink Gaming receives noncompliance notification from Nasdaq SBET SharpLink Gaming / + 11/11/22 Bet On It: Propositions to legalize sports betting in California fall short 16:30 Today SharpLink Gaming - SBET
Conference/Events	Avid Technology management to meet with B. Riley » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 AVID Avid Technology $28.09 / +1.585 (+5.98%) Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AVID Avid Technology $28.09 / +1.585 (+5.98%) 11/30/22 TV MIDTVEST expands strategic relationship with Avid Technology 11/28/22 Avid Technology appoints Deb Sanders as CCO 10/13/22 Avid Technology announces amended credit facility 09/01/22 Avid Technology to replace Plantronics in the S&P 600 at open on 9/1 AVID Avid Technology $28.09 / +1.585 (+5.98%) 08/03/22 B. Riley Avid Technology price target lowered to $34 from $45 at B. Riley 07/11/22 Rosenblatt Avid Technology initiated with a Neutral at Rosenblatt 07/06/22 JPMorgan Avid Technology initiated with an Overweight at JPMorgan 05/25/22 Northland Avid Technology price target raised to $53 from $48 at Northland AVID Avid Technology $28.09 / +1.585 (+5.98%) 11/08/22 Avid Technology sees FY22 adjusted EPS $1.40-$1.50, consensus $1.44 11/08/22 Avid Technology reports Q3 adjusted EPS 38c, consensus 31c 08/02/22 Avid Technology reports Q2 EPS 16c, consensus 25c AVID Avid Technology $28.09 / +1.585 (+5.98%) 11/08/22 Fly Intel: After-Hours Movers 08/30/22 What You Missed On Wall Street On Tuesday 08/30/22 What You Missed On Wall Street This Morning 08/29/22 Fly Intel: After-Hours Movers 00:00 Today Avid Technology 12/07/22 Avid Technology
Conference/Events	Shopify management to meet with JMP Securities » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 SHOP Shopify $40.86 / +3.715 (+10.00%) Luncheon meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SHOP Shopify $40.86 / +3.715 (+10.00%) 11/29/22 Shopify reports Black Friday Cyber Monday weekend sales up 19% y/y 11/28/22 Shopify rises 8.8% 11/28/22 Shopify rises 8.3% 11/27/22 Fly Intel: Top five weekend stock stories SHOP Shopify $40.86 / +3.715 (+10.00%) 11/29/22 Jefferies Shopify BFCM results may point to Q4 tracking ahead of consensus, says Jefferies 11/29/22 UBS Affirm initiated with a Neutral at UBS 11/15/22 MoffettNathanson Shopify initiated with a Market Perform at MoffettNathanson 10/28/22 Wells Fargo Shopify price target raised to $42 from $38 at Wells Fargo SHOP Shopify $40.86 / +3.715 (+10.00%) 10/27/22 Shopify reports Q3 adjusted EPS (2c), consensus (10c) 10/26/22 Notable companies reporting before tomorrow's open 10/26/22 Notable companies reporting before tomorrow's open 07/27/22 Shopify reports Q2 adjusted EPS (3c), consensus 3c SHOP Shopify $40.86 / +3.715 (+10.00%) 10/13/22 E-commerce sites scale back ops amid online shopping shift, Bloomberg reports 09/02/22 Jury says Shopify owes $40M for website IP patent infringement, Reuters reports 08/19/22 Walmart may launch platform using social media influencers, Reuters reports 08/09/22 Cathie Wood's funds sold over 1.4M Coinbase shares on July 26, Bloomberg says SHOP Shopify $40.86 / +3.715 (+10.00%) 11/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/25/22 Sell these stocks now, proven algorithm says 11/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/27/22 What You Missed On Wall Street On Thursday 00:00 Today Shopify SHOP Shopify $40.86 / +3.715 (+10.00%) 11/30/22 Shopify call volume above normal and directionally bullish 11/15/22 Shopify call volume above normal and directionally bullish 10/27/22 Unusually active option classes on open October 27th 07/28/22 Largest borrow rate increases among liquid names
Conference/Events	First Foundation management to meet with Stephens » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 FFWM First Foundation $14.00 / +0.3 (+2.19%) Meeting to be held with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options FFWM First Foundation $14.00 / +0.3 (+2.19%) 11/21/22 First Foundation announces CEO Scott Kavanaugh named president 11/08/22 First Foundation says president DePillo to leave, CFO Thompson named interim FFWM First Foundation $14.00 / +0.3 (+2.19%) 10/26/22 DA Davidson First Foundation downgraded to Neutral from Buy at DA Davidson 07/27/22 B. Riley First Foundation price target raised to $23 from $21 at B. Riley 07/11/22 B. Riley First Foundation downgraded to Neutral from Buy at B. Riley 04/12/22 B. Riley First Foundation price target lowered to $31 from $34 at B. Riley FFWM First Foundation $14.00 / +0.3 (+2.19%) 10/25/22 First Foundation reports Q3 EPS 51c, consensus 51c 07/26/22 First Foundation reports Q2 EPS 59c, consensus 53c 07:30 Today First Foundation FFWM First Foundation $14.00 / +0.3 (+2.19%) 09/21/22 Seventeen new option listings on September 21st
Conference/Events	Veracyte management to meet virtually with Stephens » 04:55 12/01/22 12/01 04:55 12/01/22 04:55 VCYT Veracyte $27.78 / +2.25 (+8.81%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events VCYT Veracyte $27.78 / +2.25 (+8.81%) 10/17/22 Exagen appoints John Aballi as CEO 09/22/22 Veracyte announces VANDAAM trial data published in journal 09/11/22 Veracyte announces new data from Phase 3 of STAMPEDE platform protocol 09/07/22 Veracyte's Envisia Genomic Classifier may predict lung disease progression VCYT Veracyte $27.78 / +2.25 (+8.81%) 05/04/22 Needham Veracyte price target lowered to $26 from $31 at Needham 03/15/22 Needham Needham drops Veracyte target, says shares undervalued 03/01/22 Lake Street Veracyte price target lowered to $50 from $95 at Lake Street 03/01/22 Needham Veracyte price target lowered to $35 from $55 at Needham VCYT Veracyte $27.78 / +2.25 (+8.81%) 11/02/22 Veracyte raises FY2 revenue view to $288M-$293M from $272M-$280M 11/02/22 Veracyte reports Q3 EPS (12c), consensus (25c) 08/02/22 Veracyte raises FY22 revenue view to $272M-$280M, consensus $272.42M 08/02/22 Veracyte reports Q2 EPS (13c), consensus (22c) VCYT Veracyte $27.78 / +2.25 (+8.81%) 11/07/22 Biotech Alert: Searches spiking for these stocks today 07/13/22 Fly Intel: After-Hours Movers 00:00 Today Veracyte

Events

Earnings calls, analyst events, roadshows and more

Today at 07:30

Challenger Job-Cut Report Level: November 2022 Government Event
YI
Today at 07:30

111, Inc. - YI Conference Calls
CM
Today at 07:30

CIBC - CM Conference Calls
FFWM
Today at 07:30

First Foundation Firm Sponsored Meetings

Boston, MA
VSCO
Today at 08:00

Victoria's Secret - VSCO Conference Calls
SCWX
Today at 08:00

Secureworks - SCWX Conference Calls
BIG
Today at 08:00

Big Lots - BIG Conference Calls
Today at 08:30

Personal Consumption Expenditures M/M: October 2022 Government Event
Today at 08:30

PCE Price Index M/M: October 2022 Government Event
Today at 08:30

Initial Jobless Claims Change: Week 11/26/2022 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	TCRT X TCRT Alaunos Therapeutics Spot Secondary Managers: Cantor Fitzgerald Priced at: $.65 24.228M Shares
Tues	ASAI X ASAI Sendas Distribuidora Secondary Managers: Itau BBA, BTG Pactual & JPMorgan, Safra Securities, Santander Priced at: $17.90 Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASPN X ASPN Aspen Aerogels Spot Secondary Managers: Cowen & Barclays Priced at: $9.50 25.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASTS X ASTS AST SpaceMobile Spot Secondary Managers: B. Riley Priced at: $5.50 13.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AURA X AURA Aura Biosciences Spot Secondary Managers: SVB Securities, Cowen & Evercore ISI, JMP Securities, BTIG Priced at: $12.00 6.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	AZYO X AZYO Aziyo Biologics Spot Secondary Managers: Cantor Fitzgerald $6.90 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTO X CTO CTO Realty Growth Spot Secondary Managers: Wells Fargo & Raymond James $19.00-20.00 2.5M Shares FREY X FREY Freyr Battery Spot Secondary Managers: Credit Suisse, BofA & Morgan Stanley $11.25-11.75 13.5M Shares ISEE X ISEE Iveric bio Spot Secondary Managers: Cowen & Stifel $21.50-22.50 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NTLA X NTLA Intellia Therapeutics Spot Secondary Managers: Goldman Sachs $45.80-47.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	SHLS X SHLS Shoals Technologies Secondary Managers: JPMorgan, Guggenheim & Morgan Stanley $28.97 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

NYSE market internals summary

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access